A team from Vischer, led by partner Thomas Weibel (pictured), have taken part in the successful return of several million euros to Switzerland for a Swiss private bank, which had been transferred to an offshore
Search Results for: vischer
Online voting is the first step on the path towards the Legalcommunity Awards Ceremony taking place during the Gala Dinner on 05th of May 2022 in Zurich. In collaboration with the European Chapter of the Association
Anaveon, a Swiss clinical-stage immuno-oncology company, has agreed to a CHF 110 million Series B financing led by incoming investor Forbion, corner-stoned by founding investor Syncona, also joined by existing investor Novartis Venture Fund, as well
Bookselling company Orell Füssli Thalia acquired a stake as lead investor in the digital community platform Evrlearn. With the new partnership, both companies are strengthening their educational activities in B2C and B2B.
Alloy Therapeutics, a Boston based biotechnology ecosystem company, has entered into a definitive agreement to acquire deepCDR Biologics, a privately held Basel based developer of deep learning technology for antibody discovery and optimisation. Alloy will
Mainova, an energy supplier based in Frankfurt am Main, has acquired a majority stake in the Bavarian energy service provider mobiheat, including its subsidiaries in Austria and Switzerland, from Energieversorgung Offenbach (EVO) and the mobiheat
Procimmo Swiss Commercial Fund II (PSCFII), an investment fund incorporated under Swiss law, has acquired the Sun and Vsp industry sites from Sun Bürglen and thereby strengthens its real estate portfolio. Vischer advised the
msg systems, an international IT consulting and system integration company based in Munich, has acquired Optravis, a provider of SaaS solutions in operational transfer pricing management based in Basel. The terms of the deal were
Online voting is the first step on the path towards the Legalcommunity Awards Ceremony taking place during the Gala Dinner on 10th of February 2022 in Zurich. The award ceremony will acknowledge the best in the
Relief Therapeutics, a biopharmaceutical company, has launched a Level 1 American Depositary Receipt (“ADR”) program in the United States. From 18 November 2021, ADRs can be traded over-the-counter. Relief’s ADR program complements the existing main listing of